Menu

Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6062403)

Succinylchloline Chloride 50 mg per ml, 2 ml Inj,Cap Tacrolimus 0.25 mg,Flavoxate 200mg Tab,Erythro

Goods
Qty:47.3K
Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6062403)

Tender Timeline

Tender Issue
April 25, 2025 at 9:26 AM

Tender Title: Procurement of Pharmaceuticals

Tender Reference Number: GEM/2025/B/6062403
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The tender seeks bids for the procurement of pharmaceuticals, particularly focusing on a variety of critical medicinal products. The primary items required include Succinylchloline Chloride 50 mg per ml (2 ml Inj), Cap Tacrolimus 0.25 mg, Flavoxate 200 mg Tablets, and Erythromycin. The total quantity required for procurement is 47,290 units, which is oriented towards ensuring the consistent supply of essential medicines for military and defense personnel.

The scope of work encapsulates the supply and delivery of the specified medications in accordance with the technical and quality standards required by the Indian military health system. Interested vendors should possess the capacity to supply high-quality pharmaceuticals promptly and efficiently.

Eligibility Criteria

Vendors wishing to participate must meet specific eligibility criteria:

  • Be a registered entity with relevant experience in pharmaceutical supply.
  • Possess all necessary accreditations and licenses as mandated by Indian health authorities.
  • Demonstrate a track record of timely delivery and high-quality standards in similar contracts.

Technical Requirements

The technical requirements set forth in this tender mandate that all pharmaceuticals supplied must comply with the standards established by the Central Drugs Standard Control Organization (CDSCO) and related health authorities. Certificates of analysis for each batch delivered must be included, and suppliers should adhere to Good Manufacturing Practices (GMP).

Financial Requirements

Prospective bidders must provide evidence of financial stability and capability to undertake the supply order. This includes audited financial statements for the previous three years and proof of existing contracts of similar size and nature.

Document Submission Details

Bids must be submitted online through the designated government e-marketplace platform, ensuring adherence to submission guidelines outlined in the tender documentation. All documents must be uploaded in acceptable formats as stipulated in the submission guidelines.

Special Provisions

The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups, providing them with benefits as per government policies. These provisions aim to foster inclusivity and support emerging businesses in contributing to defense needs.

Evaluation Process

The evaluation of bids will be carried out based on technical compliance, financial robustness, and pricing. A quality and quantity assessment will ensure that only those bids that meet or exceed set technical specifications proceed to the financial evaluation stage. Competence in meeting delivery commitments will also weigh heavily in the decision-making process.

Delivery Locations

The pharmaceuticals must be delivered to specified military healthcare facilities across the nation, ensuring robust supply chain management practices are in place to meet logistical requirements.

Contact Information

For inquiries regarding the tender, vendors can contact the Department of Military Affairs through the official channels provided in the government e-marketplace platform.

This procurement opportunity represents a significant commitment to maintaining the health and wellness of service personnel and ensures that those responsible for their care have access to the necessary medical supplies required for optimal service readiness.


General Information

Item Category
Succinylchloline Chloride 50 mg per ml, 2 ml Inj , Cap Tacrolimus 0.25 mg , Flavoxate 200mg Tab , Erythropoeitin Human Recombinant 4000 IU , Papaverine Hydrochloride 50 mg, 2 ml Inj , Sevelamer Carbonate Sachet 800mg , Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen , Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml , Brimonidine Tartrate 0.2 percent, Eye drops , Clobazam 5 mg Tab , Lorazepam 2 mg per ml, 2 ml Inj , Gabapentin 300 mg Cap or Tab , Sodium Valproate 100 mg per ml Inj , Lamotrigine 25 mg Tab , Sumatriptan 50 mg Tab , Topiramate 25 mg Tab , Nimodipine 30 mg Tab , Canagliflozin 100mg tab , Carbimazole 20 mg Tab , Tab Tenofovir 300mg , Tab Entacavir 0.5mg , Omeprazole 20 mg Cap , Pantoprazole 40mg Inj , Ranitidine HCl 50 mg, 2 ml Inj , Metoclopramide syrup 5mg per 5ml bott of 30ml , Hydrocortisone Enema 10 percentage , Dicyclomine HCl 20 mg Inj , Tab or Cap Dicyclomine 10mg , Bisacodyl 5 mg Tab , Sodium phosphate solution 45 ml, each Pack of 2 bottle , Tab Dapagliflozin 10mg , Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... , Baclofen XL 30 mg Tab , Clozapine 50 mg Tab , Ranolazine 500 mg Tab , Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab
Ministry Name
Organisation Name

Financial Information

Bid Offer Validity
180 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7651285.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Ketamine HCl 50 mg per ml 2 ml Inj,Bupivacaine HCl 5 mg per ml Inj,Fentanyl Citrate 50mcg per ml 2

GEM
Goods
Qty:33.9K
4 Files
Indian Army
KARGIL, JAMMU & KASHMIR
Boq › Boql
Ketamine HCl 50 mg per ml 2 ml Inj , Bupivacaine HCl 5 mg per ml Inj , Fentanyl Citrate 50mcg per ml 2 ml Inj , Dexamethasone 0.5 mg Tab , Baclofen 10 mg Tab , Inj Tenecteplase 20 mg , Enoxaparin 40 mg per 0.4ml Inj , Cilnidipine 5 mg Tab , Cap Probiotic , Itraconazole 100mg Cap , Oral Rehydration powder sachet of 20.5 g , Thyroxine Sodium 0.1mg Tab , Fluticasone Propionate 50 mcg BP Nasal Spray , Clonazepam 0.5 mg Tab , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg , Nortriptyline 25 mg Tab , Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule , Micronized Purified Flavonoid Fraction of rutaceae 500mg Tab , Tamsulosin HCl 0.4mg Cap , B1 50 mg Inj , Formeterol 6mcg and Budesonide 400 mcgC FC Free MDI 120 Meter dose , Levo- Salbutamol 1.25mg with Ipratropium 500 mcg in 2.5 ml Respule , Fexofenadine Hydrochloride Tab 120 mg , Amoxycillin 1g with Clavulanic Acid 200mg 1.2 gm Inj , Cefoperazone Sodium 1gm and sulbactum Sod 1gm Inj , Teicoplanin 400 mg Inj , Vancomycin CP 500 mg Inj , Meropenem 500 mg Inj , Gauze Surgical Open Wove Unmedicated 60 cm wide , HIV antibody 1 and 2 detection rapid test kit , Troponin T Test card , Rapid card screening for HBV kit of 50 test , Rapid card screening for HCV kit of 50 test , Tab Pantoprazole with Domperidone , Lyse solution, bott of 500ml , Cell Pack pack of 20 ltr , Tab Nilotinib 200mg , Syp Disodium Hydrogen Alkasol, bott of 100 ml , Dengue test card kit of 20 test , Malaria test card kit of 50 test , Typhi Dot test card kit of 50 test , Glucose strip Accu check , Glucometer Cell , Cap Diacerine 50mg , Medical Dry Film 10 inch and 8 inch Fujifilm , Sample Cup , Roter 180 Fully Automatic Machine Erba , Sodium Potassium Chloride kit 180 Fully Automatic , Cholestrol Kit 180 Fully Automatic Erba , Lipase Kit 180 Fully Automatic Erba , CKMB Kit 180 Fully Automatic Erba , CRP Kit 180 Fully Automatic Erba , LDH Kit 180 Fully Automatic Erba , Multi Cal Kit 180 Fully Automatic Erba , ERBA Auto Wash 180 Fully Automatic Erba , ERBA Norm 180 Fully Automatic Erba , ERBA Path 180 Fully Automatic Erba
April 26, 2025
May 17, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity with relevant experience in pharmaceutical supply, possessing the necessary accreditations and licenses mandated by Indian health authorities, and demonstrating a proven track record of timely delivery and compliance with quality standards in similar contracts. Potential bidders should ensure their qualifications align with the objectives outlined in the tender documentation.

Bidders must submit several required certificates, including compliance with Good Manufacturing Practices (GMP), valid licenses for the production and supply of pharmaceuticals, and certificates of analysis for each batch of products. All submitted documents must verify adherence to quality standards delineated by the Central Drugs Standard Control Organization (CDSCO).

The registration process requires bidders to create an account on the designated government e-marketplace platform. After successful registration, vendors must verify their credentials and ensure compliance with the eligibility criteria specified in the tender documentation before proceeding to submit their offers.

Among the accepted document formats, bidders should use common file types such as PDF, DOCX, and XLSX. It is essential to refer to the submission guidelines provided with the tender for any specific formatting requirements that may pertain to the documents submitted.

The tender includes special provisions for MSEs that encourage participation by providing benefits such as relaxed qualification criteria, financial advantages, and additional support to help smaller firms compete with larger suppliers. This initiative aims to enhance the participation of MSEs in government contracts and promote local production capabilities.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders